Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
BMC Genomics
|
May 18, 2022
PhyloMissForest: a random forest framework to construct phylogenetic trees with missing data
Diogo Pinheiro, Sergio Santander-Jimenéz, Aleksandar Ilic
Scientific Reports
|
June 25, 2024
Distributed transformer for high order epistasis detection in large-scale datasets
Miguel Graça, Ricardo Nobre, Leonel Sousa, et al.
Vaccine
|
November 20, 2025
Evaluating the implementation of the 20-valent pneumococcal conjugate vaccine for paediatric immunization in Australia
Valda Anne Struwig, An Ta, Amit Vilas Thorat, et al.
Vaccines
|
November 26, 2024
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
Aleksandar Ilic, Maria J Tort, Alejandro Cane, et al.
Infectious Diseases and Therapy
|
February 3, 2025
Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit
Johnna Perdrizet, An Ta, Liping Huang, et al.
Infectious Diseases and Therapy
|
February 6, 2025
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme
Esra Çakar, An Ta, Michel Peters, et al.
Journal of Medical Economics
|
April 30, 2025
Cost-effectiveness analysis of implementing 20-valent pneumococcal conjugate vaccine into the Romanian pediatric national immunization program
Alin Preda, An Ta, Elizabeth Vinand, et al.
Infectious Diseases Now
|
May 10, 2025
Impact of delaying PCV20 implementation in France's pediatric national immunization program: A population-based Markov model
Johnna Perdrizet, Emmanuelle Blanc, Jessica Y El Khoury, et al.
Epigenetics & Chromatin
|
November 12, 2017
Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites
Aleksandar Ilic, Sumin Lu, Vikram Bhatia, et al.
Journal of Medical Economics
|
July 21, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany
Johnna Perdrizet, Dominik Schröder, Felicitas Kühne, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
BMC Genomics
|
May 18, 2022
PhyloMissForest: a random forest framework to construct phylogenetic trees with missing data
Diogo Pinheiro, Sergio Santander-Jimenéz, Aleksandar Ilic
Scientific Reports
|
June 25, 2024
Distributed transformer for high order epistasis detection in large-scale datasets
Miguel Graça, Ricardo Nobre, Leonel Sousa, et al.
Vaccine
|
November 20, 2025
Evaluating the implementation of the 20-valent pneumococcal conjugate vaccine for paediatric immunization in Australia
Valda Anne Struwig, An Ta, Amit Vilas Thorat, et al.
Vaccines
|
November 26, 2024
The Health and Economic Effects of PCV15 and PCV20 During the First Year of Life in the US
Aleksandar Ilic, Maria J Tort, Alejandro Cane, et al.
Infectious Diseases and Therapy
|
February 3, 2025
Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit
Johnna Perdrizet, An Ta, Liping Huang, et al.
Infectious Diseases and Therapy
|
February 6, 2025
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme
Esra Çakar, An Ta, Michel Peters, et al.
Journal of Medical Economics
|
April 30, 2025
Cost-effectiveness analysis of implementing 20-valent pneumococcal conjugate vaccine into the Romanian pediatric national immunization program
Alin Preda, An Ta, Elizabeth Vinand, et al.
Infectious Diseases Now
|
May 10, 2025
Impact of delaying PCV20 implementation in France's pediatric national immunization program: A population-based Markov model
Johnna Perdrizet, Emmanuelle Blanc, Jessica Y El Khoury, et al.
Epigenetics & Chromatin
|
November 12, 2017
Ubiquitin C-terminal hydrolase isozyme L1 is associated with shelterin complex at interstitial telomeric sites
Aleksandar Ilic, Sumin Lu, Vikram Bhatia, et al.
Journal of Medical Economics
|
July 21, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany
Johnna Perdrizet, Dominik Schröder, Felicitas Kühne, et al.
Page
of 2